成年早期FEV1减少的异质性:一项前瞻性和回顾性分析。

IF 6.6 2区 医学 Q1 RESPIRATORY SYSTEM
Respirology Pub Date : 2025-01-12 DOI:10.1111/resp.14876
Nuria Olvera, Alvar Agusti, Judith M Vonk, Gang Wang, Jenny Hallberg, H Marike Boezen, Maarten van den Berge, Erik Melén, Rosa Faner
{"title":"成年早期FEV1减少的异质性:一项前瞻性和回顾性分析。","authors":"Nuria Olvera, Alvar Agusti, Judith M Vonk, Gang Wang, Jenny Hallberg, H Marike Boezen, Maarten van den Berge, Erik Melén, Rosa Faner","doi":"10.1111/resp.14876","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Some individuals never achieve normal peak FEV<sub>1</sub> in early adulthood. It is unknown if this is due to airflow limitation and/or lung restriction.</p><p><strong>Methods: </strong>To investigate this, we: (1) looked forward in 19,791 participants in the Dutch Lifelines general population cohort aged 25-35 years with 5-year follow-up; and (2) looked backwards in 2032 participants in the Swedish BAMSE birth cohort with spirometry at 24 years of age but also at 16 and/or 8 years.</p><p><strong>Results: </strong>(1) In Lifelines 8.5% of participants had reduced FEV<sub>1</sub> at 25-35 years, 68% due to Preserved Ratio Impaired Spirometry ('PRISm') and 32% to airflow limitation ('low-limited'); besides, 3.8% participants with normal FEV<sub>1</sub> showed airflow-limitation ('normal-limited'). Low-limited and normal-limited, but not PRISm, reported higher smoking exposures and asthma diagnosis than normal (p < 0.05). At 5-year follow-up, 91.2% of participants remained in the same group, and FEV<sub>1</sub> decline was similar in normal and normal-limited participants, but statistically smaller (p < 0.05) in PRISm and low-limited; (2) these observations were largely reproduced in BAMSE at 24 years of age; and, (3) in BAMSE, low-limited or PRISm individuals were already identifiable at 8-16 years of age.</p><p><strong>Conclusion: </strong>Low peak FEV<sub>1</sub> in early adulthood is most often due to PRISm and results in a significant burden of respiratory symptoms. Only low-limited and normal-limited, but not PRISm, associate with a doctor diagnosis of asthma, and FEV<sub>1</sub> decline was statistically different in PRISm indicating a need for differentiated clinical approaches. These spirometric abnormalities can be already identified in childhood and adolescence.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Heterogeneity of reduced FEV<sub>1</sub> in early adulthood: A looking forward, looking backwards analysis.\",\"authors\":\"Nuria Olvera, Alvar Agusti, Judith M Vonk, Gang Wang, Jenny Hallberg, H Marike Boezen, Maarten van den Berge, Erik Melén, Rosa Faner\",\"doi\":\"10.1111/resp.14876\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Some individuals never achieve normal peak FEV<sub>1</sub> in early adulthood. It is unknown if this is due to airflow limitation and/or lung restriction.</p><p><strong>Methods: </strong>To investigate this, we: (1) looked forward in 19,791 participants in the Dutch Lifelines general population cohort aged 25-35 years with 5-year follow-up; and (2) looked backwards in 2032 participants in the Swedish BAMSE birth cohort with spirometry at 24 years of age but also at 16 and/or 8 years.</p><p><strong>Results: </strong>(1) In Lifelines 8.5% of participants had reduced FEV<sub>1</sub> at 25-35 years, 68% due to Preserved Ratio Impaired Spirometry ('PRISm') and 32% to airflow limitation ('low-limited'); besides, 3.8% participants with normal FEV<sub>1</sub> showed airflow-limitation ('normal-limited'). Low-limited and normal-limited, but not PRISm, reported higher smoking exposures and asthma diagnosis than normal (p < 0.05). At 5-year follow-up, 91.2% of participants remained in the same group, and FEV<sub>1</sub> decline was similar in normal and normal-limited participants, but statistically smaller (p < 0.05) in PRISm and low-limited; (2) these observations were largely reproduced in BAMSE at 24 years of age; and, (3) in BAMSE, low-limited or PRISm individuals were already identifiable at 8-16 years of age.</p><p><strong>Conclusion: </strong>Low peak FEV<sub>1</sub> in early adulthood is most often due to PRISm and results in a significant burden of respiratory symptoms. Only low-limited and normal-limited, but not PRISm, associate with a doctor diagnosis of asthma, and FEV<sub>1</sub> decline was statistically different in PRISm indicating a need for differentiated clinical approaches. These spirometric abnormalities can be already identified in childhood and adolescence.</p>\",\"PeriodicalId\":21129,\"journal\":{\"name\":\"Respirology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respirology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/resp.14876\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respirology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/resp.14876","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:一些个体在成年早期从未达到正常的FEV1峰值。尚不清楚这是否是由于气流受限和/或肺受限所致。方法:为了研究这一点,我们:(1)对荷兰生命线普通人群队列中年龄在25-35岁的19,791名参与者进行了5年随访;(2)对瑞典BAMSE出生队列中2032名24岁、16岁和/或8岁时进行肺活量测定的参与者进行回顾性研究。结果:(1)在生命线中,8.5%的参与者在25-35岁时FEV1减少,68%是由于保留比例受损的肺活量(PRISm), 32%是由于气流限制(low-limit);此外,3.8% FEV1正常的参与者表现出气流受限(“正常受限”)。低限制组和正常限制组,但不包括PRISm组,报告的吸烟暴露和哮喘诊断高于正常组(p值下降在正常组和正常限制组中相似,但统计学上较小)。结论:成年早期低峰值FEV1最常是由于PRISm组,并导致呼吸道症状的显著负担。只有低限制和正常限制与哮喘的医生诊断相关,而PRISm与哮喘的诊断无关,并且PRISm的FEV1下降具有统计学差异,这表明需要区分临床方法。这些肺活量异常可在儿童期和青春期被发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Heterogeneity of reduced FEV1 in early adulthood: A looking forward, looking backwards analysis.

Background: Some individuals never achieve normal peak FEV1 in early adulthood. It is unknown if this is due to airflow limitation and/or lung restriction.

Methods: To investigate this, we: (1) looked forward in 19,791 participants in the Dutch Lifelines general population cohort aged 25-35 years with 5-year follow-up; and (2) looked backwards in 2032 participants in the Swedish BAMSE birth cohort with spirometry at 24 years of age but also at 16 and/or 8 years.

Results: (1) In Lifelines 8.5% of participants had reduced FEV1 at 25-35 years, 68% due to Preserved Ratio Impaired Spirometry ('PRISm') and 32% to airflow limitation ('low-limited'); besides, 3.8% participants with normal FEV1 showed airflow-limitation ('normal-limited'). Low-limited and normal-limited, but not PRISm, reported higher smoking exposures and asthma diagnosis than normal (p < 0.05). At 5-year follow-up, 91.2% of participants remained in the same group, and FEV1 decline was similar in normal and normal-limited participants, but statistically smaller (p < 0.05) in PRISm and low-limited; (2) these observations were largely reproduced in BAMSE at 24 years of age; and, (3) in BAMSE, low-limited or PRISm individuals were already identifiable at 8-16 years of age.

Conclusion: Low peak FEV1 in early adulthood is most often due to PRISm and results in a significant burden of respiratory symptoms. Only low-limited and normal-limited, but not PRISm, associate with a doctor diagnosis of asthma, and FEV1 decline was statistically different in PRISm indicating a need for differentiated clinical approaches. These spirometric abnormalities can be already identified in childhood and adolescence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Respirology
Respirology 医学-呼吸系统
CiteScore
10.60
自引率
5.80%
发文量
225
审稿时长
1 months
期刊介绍: Respirology is a journal of international standing, publishing peer-reviewed articles of scientific excellence in clinical and clinically-relevant experimental respiratory biology and disease. Fields of research include immunology, intensive and critical care, epidemiology, cell and molecular biology, pathology, pharmacology, physiology, paediatric respiratory medicine, clinical trials, interventional pulmonology and thoracic surgery. The Journal aims to encourage the international exchange of results and publishes papers in the following categories: Original Articles, Editorials, Reviews, and Correspondences. Respirology is the preferred journal of the Thoracic Society of Australia and New Zealand, has been adopted as the preferred English journal of the Japanese Respiratory Society and the Taiwan Society of Pulmonary and Critical Care Medicine and is an official journal of the World Association for Bronchology and Interventional Pulmonology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信